New CEO Joins Newly Selected Executive Officers to Optimize US
IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products and
services, today announced the appointment of Yasuhiro Yoshitake as its
new president and CEO. Yoshitake is taking over the helm of the
organization from Dr. Wilson P. Constantine, who led the organization
from April 2015 to February 2019.
Yoshitake’s appointment coincides with the realignment of U.S.
leadership, including the development of three new positions to optimize
the organization for continued growth. The new positions – a chief
operations officer, a chief financial officer and a chief commercial
officer – as well as the company’s chief technology officer, will report
directly to Yoshitake.
“The U.S. is a dynamic healthcare market that requires deep
collaboration between the corporate headquarters in Japan and the U.S.
organization,” said Hirokazu Ogino, president and CEO of Nihon Kohden
Corporation. “Yoshitake’s understanding of Nihon Kohden and deep
experience around the world will allow us to continue to build our
presence and facilitate growth in the U.S.”
Yoshitake first joined Nihon Kohden in 1988. He has held key positions
in multiple regions around the world, including Europe and China, as
well as in Asia and Middle East operations. Most recently, he served as
Nihon Kohden’s general manager of international operations and corporate
director and operating officer, which are positions that he will retain
as part of his new role.
As part of the realignment, several structural shifts have been made
across the organization, including:
Harsh Dharwad will continue in his role as vice president and chief
technology officer reporting to Yoshitake.
Scott Iserman has been promoted to chief commercial officer and will
be responsible for the commercial strategy, and for building a
commercialization infrastructure and organization that drives business
growth and market share.
Shinya Hama has been promoted to chief operations officer, responsible
for effective operations of the business, including delivery of
products and services, overall quality and utilization of resources to
Kenji Sakai joined the organization as chief financial officer,
responsible for identifying and evaluating new business opportunities
to funnel our growth, providing financial direction on larger more
complex transactions, and providing leadership to the finance
“The American healthcare market is a significant part of Nihon Kohden’s
future,” Yoshitake said. “We believe these shifts will allow us to
continue building upon the significant growth Nihon Kohden has secured
in the last few years and position us to achieve our goal of further
growing our share of the market.”
About Nihon Kohden Corporation
Founded in Japan in 1951, Nihon Kohden is a leading manufacturer,
developer and distributor of medical electronic equipment, with
subsidiaries in the U.S., Europe and Asia. The company’s products are
now used in more than 120 countries, and it is the largest supplier of
electroencephalography products worldwide. A pioneer in transformational
healthcare technology, Nihon Kohden has envisioned, designed and
produced revolutionary devices, such as pulse oximeters, arrhythmia
analysis, low-invasive blood volume monitoring and wireless patient
monitoring. In the U.S., the company is a trusted source for patient
monitoring, sleep assessment, neurology and cardiology instrumentation
solutions, and has been rated No. 1 in patient monitoring or telemetry
for more than 10 consecutive years (MD Buyline). For more information,
MD Buyline is a registered service mark of MD Buyline.
Senior Director, Communications and Public Relations